April 11 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON RECEIVES U.S. PATENT ON DRUG COMPOSITION TO TREAT CLOSTRIDIUM DIFFICILE
* IMMURON LTD - AUSTRALIAN CLINICAL SITES TO BE OPENED FOR C. DIFFICILE TRIAL
* IMMURON LTD - IMMURON PLANS TO FILE AN INVESTIGATIONAL NEW DRUG (IND) APPLICATION WITH FOOD AND DRUG ADMINISTRATION (FDA) IN U.S.